Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 92, 33-39
- https://doi.org/10.1016/s0954-6111(98)90215-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dose-Response of Inhaled Drugs in AsthmaClinical Pharmacokinetics, 1997
- Twenty-eight-day Double-blind Safety Study of an HFA-134a Inhalation Aerosol System in Healthy SubjectsJournal of Pharmacy and Pharmacology, 1996
- Fluticasone propionate — an update on preclinical and clinical experienceRespiratory Medicine, 1995
- Adverse effects of inhaled corticosteroidsThe American Journal of Medicine, 1995
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- Metered-dose inhalers and CFCs: what respiratory physicians need to knowRespiratory Medicine, 1994
- Clinical pharmacology of corticosteroids in bronchial asthmaPharmacology & Therapeutics, 1993
- The adult patient’s difficulties with inhalersLung, 1990
- Assessing the Use of Metered Dose Inhalers by Adults with AsthmaJournal of Asthma, 1989
- Beclomethasone Dipropionate A Reappraisal of its Pharmacodynamic Properties and Therapeutic Efficacy After a Decade of Use in Asthma and RhinitisDrugs, 1984